 |
市場調査レポート
商品コード
599602
世界の結核診断および治療市場調査と予測Global Tuberculosis Diagnosis and Treatment Market 2019-2025 |
||||||
| 世界の結核診断および治療市場調査と予測 |
|
出版日: 2019年10月10日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
|
当レポートでは、世界の結核診断および治療市場について調査し、市場の規模と薬剤別、診断別、エンドユーザー別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。
Title:
Global Tuberculosis Diagnosis and Treatment
Market Size, Share & Trends Analysis Report, By Diagnosis (Laboratory Testing, Nucleic Acid Tests, Radiography, Drug Susceptibility Test, and Other Tests),B Drugs (First Line Drugs and Second Line Drugs), By End-User (Hospitals & Clinics, Government & Non-Government Organizations, and Others), and Forecast 2019-2025.
The global tuberculosis diagnosis and treatment market is expected to grow at a significant rate during 2019-2025. Tuberculosis is one of the top 10 causes of global fatalities as it affects the lungs and causes life-threatening conditions in the human body. The market growth is attributed to the rising incidence of drug-susceptible (DS) tuberculosis (TB), an increase in multi-drug resistant (MDR) TB cases and increasing R&D for the development of tuberculosis drugs. In addition, robust product pipeline for the tuberculosis products and increasing initiatives by the government in emerging economies for the treatment of tuberculosis creates an ample opportunity for the growth of the market in the near future.
The global tuberculosis diagnosis and treatment market are segmented on the basis of diagnosis, drugs, and end-user. Based on the diagnosis, the market is segmented into laboratory testing, nucleic acid tests, radiography, drug susceptibility test, and other tests. Laboratory testing for tuberculosis diagnosis is expected to hold a significant share in the market owing to advancements in culture-based tests. Further, on the basis of drugs, the market is bifurcated into first-line drugs such as Pyrazinamide (Z/PZA), Ethambutol (E/EMB), Rifabutin (RFB), and Streptomycin; and second-line drugs such as Kanamycin (KM), Amikacin (AMK), and Capreomycin (CM). Based on the end-user, the market is segmented into hospitals & clinics, government & non-government organizations, and others. Hospitals & clinics are expected to contribute a major share in the market.
Geographically, the market study of the global tuberculosis diagnosis and treatment market report covers the analysis of four major region including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and Rest of the World (RoW). Increasing prevalence of tuberculosis across the globe is expected to give a boost to the growth of the market. Further, the market study covers the analysis of several players operating in the market. Some of the key players operating in the market include Abbott Laboratories, Inc., F. Hoffmann La Roche AG, Beckton, Dickinson, and Co., Otsuka Pharmaceuticals Co. Ltd., Johnson & Johnson Services, Inc., and Novartis AG.
The market study of the global tuberculosis diagnosis and treatment is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
The report is intended for tuberculosis drug manufacturers, suppliers, traders, and third-party distributors, pharmaceutical contract manufacturers, medical device companies, investing companies and potential investors, government organizations and research institutes, regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and market growth opportunities. The report will serve as a source for a 360-degree analysis of the market delivering insights into the market for making better business decisions.
Thermo Fisher Scientific, Inc.
比較リスト
